Altimmune ALT Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Altimmune in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Altimmune's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Altimmune's other income (expense)?
- Altimmune (ALT) reported other income (expense) of $1.68M in Q1 2026.
- How has Altimmune's other income (expense) changed year-over-year?
- Altimmune's other income (expense) increased by 7.8% year-over-year, from $1.56M to $1.68M.
- What is the long-term trend for Altimmune's other income (expense)?
- Over 3 years (2022 to 2025), Altimmune's other income (expense) has grown at a 26.4% compound annual growth rate (CAGR), from $2.83M to $5.72M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.